Search results for "cytochrome p450"

showing 10 items of 135 documents

Fluorescence-Based Screening of Cytochrome P450 Activities in Intact Cells

2013

Fluorimetric methods to assess cytochrome P450 (P450) activities that do not require metabolite separation have been developed. These methods make use of non- or low-fluorescent P450 substrates that produce highly fluorescent metabolites in aqueous solutions. The assays are based on the direct incubation of intact cells in culture with appropriate fluorogenic probe substrates, followed by fluorimetric quantification of the product formed and released into incubation medium. We describe a battery of fluorescence assays for rapid measurement of the activity of nine P450s involved in drug metabolism. For each individual P450 activity the probe showing the best properties (highest metabolic rat…

Background fluorescencechemistry.chemical_compoundChromatographychemistrybiologyMetabolitebiology.proteinCytochrome P450IncubationFluorescenceDrug metabolismHighly sensitive
researchProduct

The Catalytic Mechanism of Steroidogenic Cytochromes P450 from All-Atom Simulations: Entwinement with Membrane Environment, Redox Partners, and Post-…

2019

Cytochromes P450 (CYP450s) promote the biosynthesis of steroid hormones with major impact on the onset of diseases such as breast and prostate cancers. By merging distinct functions into the same catalytic scaffold, steroidogenic CYP450s enhance complex chemical transformations with extreme efficiency and selectivity. Mammalian CYP450s and their redox partners are membrane-anchored proteins, dynamically associating to form functional machineries. Mounting evidence signifies that environmental factors are strictly intertwined with CYP450s catalysis. Atomic-level simulations have the potential to provide insights into the catalytic mechanism of steroidogenic CYP450s and on its regulation by e…

Breast cancer; Cytochrome P450; Membrane modulation; Molecular dynamics; Phosphorylation; Prostate cancer; QM/MMCytochrome P450-Molecular dynamicslcsh:Chemical technology010402 general chemistryQM/MM01 natural sciencesCatalysislcsh:Chemistry03 medical and health scienceschemistry.chemical_compoundBreast cancerBiosynthesislcsh:TP1-1185PhosphorylationPhysical and Theoretical ChemistryPost-transcriptional regulation030304 developmental biologyGeneral Environmental Sciencechemistry.chemical_classification0303 health sciencesProstate cancerbiologyMechanism (biology)Membrane modulationCytochrome P450Ligand (biochemistry)0104 chemical sciencesCell biologyEnzymelcsh:QD1-999chemistryCYP17A1biology.proteinPhosphorylationCatalysts
researchProduct

Evaluation of Cytochrome P450 Activities in Human Hepatocytes In Vitro

2011

Major hepatic cytochrome P450 activities (CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4) can be simultaneously examined in human hepatocytes by incubation with a cocktail of multiple specific probes. Cocktail strategy in combination with mass spectrometry is shown to be a robust, fast, and sensitive procedure for P450 activity assessment. This procedure allows a drastic reduction of the number of cells required in the assay and sample analysis time and increases throughput and reproducibility. Major applications of the probe cocktail strategy are P450 phenotyping of hepatocytes and induction studies.

CYP2D6CYP2B6biologyBiochemistryCYP3A4ChemistryCYP1A2biology.proteinfood and beveragesCytochrome P450CYP2E1CYP2A6In vitro
researchProduct

Cytochrome P450 enzymes as human autoantigens

1991

CYP7B1CYP2B6CYP1B1ImmunologyAutoantigensMixed Function OxygenasesCytochrome P-450 Enzyme SystemCytochrome P-450 CYP1A2HumansMedicineHepatitis Chronicchemistry.chemical_classificationbiologybusiness.industryCytochrome P450Cytochrome P450 reductaseCytochrome P-450 CYP2C19EnzymeCytochrome P-450 CYP2D6LiverBiochemistrychemistrybiology.proteinAryl Hydrocarbon HydroxylasesOxidoreductasesbusinessImmunologic Research
researchProduct

Phosphorylation of carcinogen metabolizing enzymes: regulation of the phosphorylation status of the major phenobarbital inducible cytochromes P-450 i…

1989

We present data showing that the major phenobarbital inducible cytochromes P-450 (cytochrome P-450IIB1 and cytochrome P-450IIB2) were phosphorylated in intact hepatocytes. This phosphorylation was greatly increased by the cAMP derivatives N6-dibutyryl-cAMP and 8-thiomethyl-cAMP mediated by a cAMP-dependent protein kinase. Most importantly the phosphorylation status of cytochromes P-450 was shown to change in the hepatocytes after treatment with glucagon, which is known to increase the level of cAMP in hepatocytes. The observed impact of the hormone glucagon on the phosphorylation of distinct cytochrome P-450 forms in intact hepatocytes reveals the possibility that the enzyme activity of cyt…

Cancer ResearchCytochromeBlotting WesternGlucagonMixed Function OxygenasesCytochrome P-450 Enzyme SystemCyclic AMPmedicineAnimalsPhosphorylationEnzyme inducerProtein kinase AbiologyChemistryCytochrome P450General MedicineThionucleotidesGlucagonRatsmedicine.anatomical_structureBucladesineLiverBiochemistryPhenobarbitalHepatocytebiology.proteinPhosphorylationElectrophoresis Polyacrylamide GelPhenobarbitalmedicine.drugCarcinogenesis
researchProduct

Polychlorinated biphenyls, classified as either phenobarbital- or 3-methylcholanthrene-type inducers of cytochrome P-450, are both hepatic tumor prom…

1986

Abstract The cytochrome P -450 isozymes, cytochrome P -450 MC 1 and MC 2 , purified from rats treated with 3-methylcholanthrene (MC), were found by immunohistochemical staining to be strongly induced in the livers of rats treated with 3,3′, 4,4′-tetrachlorobiphenyl (TCBP), while the cytochrome P -450 isozymes, PB 1 and PB 2 , purified from the livers of rats treated with phenobarbital (PB), were shown to be induced in the livers of rats treated with 2,2′, 4,4′, 5,5′-hexachlorobiphenyl (HCBP). The latter compound also strongly induced NADPH-cytochrome P -450-reductase. Following induction, all 5 enzymes were located preferentially in the centrilobular and midzonal region of the liver acinus.…

Cancer Researchmedicine.medical_specialtyCytochromeIsozymechemistry.chemical_compoundLiver Neoplasms ExperimentalCytochrome P-450 Enzyme SystemInternal medicinemedicineAnimalsDiethylnitrosamineEnzyme inducergeographyCocarcinogenesisgeography.geographical_feature_categorybiologyCytochrome P450IsletPolychlorinated BiphenylsRatsIsoenzymesEndocrinologyLiverOncologyBiochemistrychemistryNitrosamineEnzyme InductionPhenobarbitalMethylcholanthrenebiology.proteinFemalePhenobarbitalMethylcholanthrenemedicine.drugCancer Letters
researchProduct

Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells.

1998

Cytochrome P450 (CYP) activity is very low or even absent in human hepatomas, a phenomenon that is accompanied by low levels of some liver transcription factors, notably C/EBP alpha. To investigate a possible link between this transcription factor and hepatic CYP expression, we have stably transfected HepG2 cells with a C/EBP alpha vector containing a Zn-inducible metallothionein promoter. Expression of functional C/EBP alpha up to liver levels concomitantly increased the mRNAs of several members of the CYP2 family (2B6, 2C9 and 2D6), suggesting that this transcription factor may play a relevant role in controlling the hepatic expression of CYP enzymes.

Carcinoma HepatocellularCYP2B6BiophysicsHepG2 cellTransfectionBiochemistryGene Expression Regulation EnzymologicCytochrome P-450 Enzyme SystemStructural BiologyTumor Cells CulturedGeneticsHumansMetallothioneinRNA MessengerVector (molecular biology)Molecular BiologyTranscription factorGeneCells CulturedCytochrome P-450 CYP2C9biologyChemistryNuclear ProteinsCytochrome P450Oxidoreductases N-DemethylatingCell BiologyTransfectionMolecular biologyDNA-Binding ProteinsCytochrome P-450 CYP2B6C/EBPαCytochrome P-450 CYP2D6Steroid 16-alpha-HydroxylaseHepatocyte nuclear factor 4 alphaEnzyme InductionSteroid HydroxylasesCCAAT-Enhancer-Binding Proteinsbiology.proteinAryl Hydrocarbon HydroxylasesHuman hepatocyteCytochrome P450 gene regulationTranscription Factors
researchProduct

Can Hepatoma Cell Lines be Re-differentiated to be Used in Drug Metabolism Studies?

2013

Knowledge of metabolism, enzymes so far involved, and potential enzyme-inhibiting or enzyme-inducing properties of new compounds is a key issue in drug development. Primary cultured hepatocytes, cytochrome P450 (CYP)-engineered cells and hepatoma cell lines are currently being used for this purpose, but only primary cultures can produce a metabolic profile of a drug similar to that found in vivo and can respond to inducers. Because of their limited accessibility, alternatives to replace human hepatocytes are currently being explored, including the immortalisation of hepatocytes by using different strategies (i.e. SV40 T-large antigen, conditionally immortalised hepatocytes, transfection wi…

Carcinoma Hepatocellularbiologybusiness.industryTransgeneCellular differentiationLiver NeoplasmsCytochrome P450Cell DifferentiationGeneral MedicineTransfectionToxicologyGeneral Biochemistry Genetics and Molecular BiologyBiotechnologyCell biologyMedical Laboratory TechnologyCytochrome P-450 Enzyme SystemDrug developmentCell cultureCell Line Tumorbiology.proteinHumansbusinessTranscription factorDrug metabolismTranscription FactorsAlternatives to Laboratory Animals
researchProduct

Neurosteroidogenesis in Rat Retinas

2002

Neurosteroids (steroids synthesized in the CNS) function by modulating neurotransmission. To establish an experimental model for investigation of neurosteroid synthesis and regulation, independent of blood-borne steroids, we examined the steroidogenic activity of isolated rat retinas. We identified progesterone, pregnenolone, dehydroepiandrosterone, desoxycorticosterone, 3 alpha,5 alpha-tetrahydrodesoxycorticosterone, 3 alpha-hydroxy-5 alpha-dihydroprogesterone, 17-hydroxyprogesterone, and 17-hydroxypregnenolone together with their esterified forms. As pregnenolone is the precursor of all steroids, its formation was studied in detail as an index of a steroid-synthesizing tissue. Pregnenolon…

Central Nervous SystemMaleTime FactorsNeuroactive steroidDehydroepiandrosteroneBiochemistryGas Chromatography-Mass SpectrometryRetinaCellular and Molecular NeuroscienceCyclic AMPmedicineAnimalsCholesterol Side-Chain Cleavage EnzymeLovastatinRats WistarChromatography High Pressure LiquidProgesteroneNeurotransmitter AgentsDose-Response Relationship DrugbiologyCholesterol side-chain cleavage enzymeCytochrome P450DehydroepiandrosteroneAminoglutethimideImmunohistochemistryRatsmedicine.anatomical_structureBiochemistryPregnenoloneInner nuclear layerPregnenolonebiology.proteinSteroidsLovastatinAminoglutethimidemedicine.drugJournal of Neurochemistry
researchProduct

Ethoxyresorufin-O-deethylase induction potency of polychlorinated diphenyl ethers in H4IIE rat hepatoma cells

1996

Polychlorinated diphenyl ethers (PCDEs) are structurally similar to polychlorinated biphenyls (PCBs), and some PCDE congeners have been reported to cause toxic responses similar to those caused by some of the non-ortho-substituted PCBs, which are mediated by the aryl hydrocarbon receptor (AhR). Twenty-nine PCDEs were tested for their potency as AhR agonists relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) by measuring their ability to induce the cytochrome P-450 1A1-associated enzyme activity, ethoxyresorufin-O-deethylase (EROD), in the H4IIE rat hepatoma cell bioassay. All PCDE congeners tested were found to be inactive as EROD inducers except for PCDE 156, which was a weak E…

ChromatographybiologyStereochemistryHealth Toxicology and MutagenesisCytochrome P450Biological activityEtherAryl hydrocarbon receptorPolychlorinated diphenyl etherschemistry.chemical_compoundchemistrybiology.proteinEnvironmental ChemistryBioassayEnzyme inducerPolychlorinated dibenzofuransEnvironmental Toxicology and Chemistry
researchProduct